1. Home
  2. MDB vs BIIB Comparison

MDB vs BIIB Comparison

Compare MDB & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDB
  • BIIB
  • Stock Information
  • Founded
  • MDB 2007
  • BIIB 1978
  • Country
  • MDB United States
  • BIIB United States
  • Employees
  • MDB N/A
  • BIIB N/A
  • Industry
  • MDB Computer Software: Prepackaged Software
  • BIIB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDB Technology
  • BIIB Health Care
  • Exchange
  • MDB Nasdaq
  • BIIB Nasdaq
  • Market Cap
  • MDB 15.8B
  • BIIB 18.7B
  • IPO Year
  • MDB 2017
  • BIIB 1991
  • Fundamental
  • Price
  • MDB $309.13
  • BIIB $132.22
  • Analyst Decision
  • MDB Strong Buy
  • BIIB Buy
  • Analyst Count
  • MDB 34
  • BIIB 27
  • Target Price
  • MDB $317.59
  • BIIB $188.09
  • AVG Volume (30 Days)
  • MDB 4.0M
  • BIIB 1.4M
  • Earning Date
  • MDB 08-26-2025
  • BIIB 10-29-2025
  • Dividend Yield
  • MDB N/A
  • BIIB N/A
  • EPS Growth
  • MDB N/A
  • BIIB 31.67
  • EPS
  • MDB N/A
  • BIIB 10.45
  • Revenue
  • MDB $2,218,189,000.00
  • BIIB $9,997,000,000.00
  • Revenue This Year
  • MDB $15.23
  • BIIB $2.00
  • Revenue Next Year
  • MDB $15.87
  • BIIB N/A
  • P/E Ratio
  • MDB N/A
  • BIIB $12.64
  • Revenue Growth
  • MDB 21.91
  • BIIB 3.36
  • 52 Week Low
  • MDB $140.78
  • BIIB $110.04
  • 52 Week High
  • MDB $370.00
  • BIIB $206.70
  • Technical
  • Relative Strength Index (RSI)
  • MDB 78.34
  • BIIB 46.86
  • Support Level
  • MDB $212.31
  • BIIB $135.22
  • Resistance Level
  • MDB $321.57
  • BIIB $138.50
  • Average True Range (ATR)
  • MDB 10.31
  • BIIB 3.37
  • MACD
  • MDB 11.37
  • BIIB -0.47
  • Stochastic Oscillator
  • MDB 97.12
  • BIIB 28.22

About MDB MongoDB Inc.

Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.

About BIIB Biogen Inc.

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

Share on Social Networks: